Hyperspectral Microscopy

Developing novel methods of biomedical diagnostics using hyperspectral microscopy to characterise natural colour and morphology of cells and tissues in the body, to determine whether they carry the early hallmarks of disease. This can yield early screening systems for detecting ill but pre-symptomatic individuals.

Competitive advantage

The method is non-invasive, rapid and easily deployable in the clinic
The first team to extract detailed biochemical-level information from cells and tissues
The method is highly sensitive and provides subtle insights into biological processes
Awarded the Eureka Prize for Innovative Use of Technology

Impact

This method is expected to impact a broad range of disease conditions, including:

Improved therapies for regenerating cartilage injuries
Improved diagnostics of cancer of ocular surface
Early diagnostics of kidney disease
Applications in fertility and IVF industry
Veterinary applications

Successful outcomes

Early diagnostics of motor neurone diseases (clinical trial under way)
Related start-up company is in its 5th year of operation

Capabilities and facilities

High-content, high-throughput imaging
Big data analytics
Bioimaging, biosensing and data analytics

Competitive advantage

Impact

Successful outcomes

Capabilities and facilities

Our partners